- €241.01m
- €124.38m
- €162.03m
- 55
- 39
- 18
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 69.5 | 65.9 | 94.8 | 147 | 162 |
Cost of Revenue | |||||
Gross Profit | 65.5 | 63.1 | 90.5 | 135 | 153 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 94.6 | 83.1 | 225 | 213 | 193 |
Operating Profit | -25 | -17.2 | -130 | -65.7 | -31.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -29.6 | -25.1 | -167 | -58.7 | -28.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -29.4 | -23.8 | -167 | -53.5 | -28.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -29.4 | -23.8 | -167 | -53.5 | -28.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -29.4 | -23.8 | -167 | -53.5 | -28.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.07 | -0.866 | -2.07 | -0.441 | -0.221 |
Dividends per Share |